• Info
  • Significant Ownership

Significant Ownership of Dimension Capital I, L.P.

Signature - Title
/s/ Adam Goulburn - By: Dimension Capital I GP, LP, its general partner; By: Adam Goulburn, Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dimension Capital I, L.P..

Notify me when Dimension Capital I, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Dimension Capital I, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLUE Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.7% $88,799,995 +$14,201,407 5,663,265 +19% Adam Goulburn 31 Dec 2025

Schedules 13D/G Reported by Dimension Capital I, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.